Kristina K Hardy1, Victoria W Willard1, Alissa B Wigdor1, Taryn M Allen1, Melanie J Bonner1. 1. Center for Neuroscience and Behavioral Medicine, Neuropsychology Division, Children's National Medical Center, Department of Psychiatry & Behavioral Medicine, George Washington University School of Medicine , Washington, DC (K.K.H.); Department of Psychology & Neuroscience , Duke University, Durham, North Carolina (currently affiliated with Department of Psychology, St. Jude Children's Research Hospital, Memphis, Tennessee) (V.W.W., A.B.W., T.M.A.); Departments of Psychiatry and Surgery, Duke University Medical Center, Department of Psychology & Neuroscience , Duke University , Durham, North Carolina (M.J.B.).
Abstract
BACKGROUND: Survivors of childhood cancer are at risk for neuropsychological late effects, yet identifying those in need of evaluation and obtaining needed services can be challenging for the medical team. Finding time- and cost-effective screening measures that can be used to identify children in need of evaluation is a clinical priority. Our objective was to investigate the association between parent-rated attention problems and related neuropsychological impairments in childhood cancer survivors as a means of identifying those at high risk for difficulties. METHODS: Cognitive and psychosocial data of survivors who completed neuropsychological evaluations were retrospectively abstracted. Parents of 70 survivors of pediatric cancer (mean age, 11.6 years) completed the Conners Parent Rating Scale and the Child Behavior Checklist. Children also completed a measure of intellectual functioning. The 18 symptoms of inattention and hyperactivity were abstracted from the Conners questionnaire, and participants were classified according to whether or not they met attention deficit/hyperactivity disorder (ADHD) symptom criteria (≥6 inattentive symptoms). RESULTS: Survivors who met symptom criteria for ADHD (27%) demonstrated greater impairments in IQ and working memory, but not processing speed, than survivors who did not. Meeting ADHD symptom criteria was also associated with greater externalizing and social problems but not more internalizing symptoms. ADHD symptom screening was associated with low sensitivity (range = 26.3%-69.2%) but stronger specificity (range = 75.0%-82.7%) for neuropsychological difficulties. CONCLUSION: Parental ratings of attentional symptoms may be a useful way to screen survivors who may be in need of a full neuropsychological assessment.
BACKGROUND: Survivors of childhood cancer are at risk for neuropsychological late effects, yet identifying those in need of evaluation and obtaining needed services can be challenging for the medical team. Finding time- and cost-effective screening measures that can be used to identify children in need of evaluation is a clinical priority. Our objective was to investigate the association between parent-rated attention problems and related neuropsychological impairments in childhood cancer survivors as a means of identifying those at high risk for difficulties. METHODS: Cognitive and psychosocial data of survivors who completed neuropsychological evaluations were retrospectively abstracted. Parents of 70 survivors of pediatric cancer (mean age, 11.6 years) completed the Conners Parent Rating Scale and the Child Behavior Checklist. Children also completed a measure of intellectual functioning. The 18 symptoms of inattention and hyperactivity were abstracted from the Conners questionnaire, and participants were classified according to whether or not they met attention deficit/hyperactivity disorder (ADHD) symptom criteria (≥6 inattentive symptoms). RESULTS: Survivors who met symptom criteria for ADHD (27%) demonstrated greater impairments in IQ and working memory, but not processing speed, than survivors who did not. Meeting ADHD symptom criteria was also associated with greater externalizing and social problems but not more internalizing symptoms. ADHD symptom screening was associated with low sensitivity (range = 26.3%-69.2%) but stronger specificity (range = 75.0%-82.7%) for neuropsychological difficulties. CONCLUSION: Parental ratings of attentional symptoms may be a useful way to screen survivors who may be in need of a full neuropsychological assessment.
Entities:
Keywords:
ADHD; attention problems; late effects; neurocognition; neuropsychological screening; pediatric cancer survivors
Authors: Raymond K Mulhern; Holly A White; John O Glass; Larry E Kun; Laurie Leigh; Stephen J Thompson; Wilburn E Reddick Journal: J Int Neuropsychol Soc Date: 2004-03 Impact factor: 2.892
Authors: Kevin R Krull; Raja B Khan; Kirsten K Ness; Davonna Ledet; Liang Zhu; Ching-Hon Pui; Scott C Howard; Deo Kumar Srivastava; Noah D Sabin; Melissa M Hudson; E Brannon Morris Journal: Pediatr Blood Cancer Date: 2011-01-28 Impact factor: 3.167
Authors: Leanne Embry; Robert D Annett; Alicia Kunin-Batson; Sunita K Patel; Stephen Sands; Gregory Reaman; Robert B Noll Journal: Pediatr Blood Cancer Date: 2012-05-03 Impact factor: 3.167
Authors: Victoria W Willard; Heather M Conklin; Frederick A Boop; Shengjie Wu; Thomas E Merchant Journal: Int J Radiat Oncol Biol Phys Date: 2014-01-22 Impact factor: 7.038
Authors: Christopher Janson; Wendy Leisenring; Cheryl Cox; Amanda M Termuhlen; Ann C Mertens; John A Whitton; Pamela Goodman; Lonnie Zeltzer; Leslie L Robison; Kevin R Krull; Nina S Kadan-Lottick Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-10 Impact factor: 4.254
Authors: Jin-Shei Lai; Corey Bregman; Frank Zelko; Cindy Nowinski; David Cella; Jennifer J Beaumont; Stewart Goldman Journal: Qual Life Res Date: 2017-04-26 Impact factor: 4.147
Authors: Christina M Sharkey; Ashley H Clawson; Larry L Mullins; Tara M Brinkman; Ching-Hon Pui; Melissa M Hudson; Kevin R Krull Journal: Pediatr Blood Cancer Date: 2019-04-29 Impact factor: 3.167
Authors: Kristina K Hardy; Victoria W Willard; Anthony Gioia; Christina Sharkey; Karin S Walsh Journal: Neuro Oncol Date: 2018-04-09 Impact factor: 12.300
Authors: Allison P Fisher; Lisa M Gies; Leah Chapman; Jessica M Aguilar; Keith Owen Yeates; H Gerry Taylor; Shari L Wade Journal: Clin Neuropsychol Date: 2020-12-29 Impact factor: 4.373